Title(s)
- Neurologist
- Neurohospitalist
- Epidemiologist
Biographical Sketch
Dr Sejvar is board-certified in Neurology and holds additional training in epidemiology and infectious diseases. Before coming to the University of Pittsburgh in 2023, he spent the bulk of his career at the U.S. Centers for Disease Control and Prevention, where he ran the Neuroepidemiology Unit. His interests and research include global neurology and infections of the nervous system, including encephalitis, meningitis, and acute flaccid paralysis
Education & Training
- Fellowship, Centers for Disease Control and Prevention, Epidemic Intelligence Service (EIS)
- Residency, Mayo Clinic, Neurology
- Internship, Mercy Hospital of Pittsburgh, Internal Medicine
- MD, Dartmouth Medical School
- BA, Case Western Reserve University, Biology
Specialized Areas of Clinical, Research and/or Educational Interests
- Nervous system infections
- Prion disease
- Acute flaccid paralysis
- Tropical neurology
Board Certifications
- Neurology
Professional Organization Memberships
- American Academy of Neurology
- American Society for Tropical Medicine and Hygiene
- Infectious Disease Society of America
Honors & Awards
- Nominee, Charles C. Shepard Science Award, PLoS One 2013, 2014
- Charles C. Shepard Science Award, PLoS One 2010, 2011
- Director's Recognition Award, National Center for Emerging and Zoonotic Infectious Diseases, 2011
- Letter of Appreciation, Texas Department of State Health Services, Investigation of Cluster of Unexplained Deaths and Illnesses, 2007
- Certificate of Appreciation, Yellow Fever Vaccine Safety Team, Division of Global Migration and Quarantine, CDC, 2006
- Honor Award, National Center for Infectious Diseases, CDC, Response to West Nile Virus, 2005
- Letter of Appreciation, Federal Emergency Management Agency and the New York State Emergency Management Office, September 11 Word Trade Center Response, 2022
- Honor Award, Program Operations, Florida and North Carolina Anthrax Investigations Teams, NCID, CDC, 2022
- Honor Award, Contributions to Health and Safety, Anthrax Efficacy, Adverse Events and Adherence, NCID, CDC, 2022
- PHS Crisis Response Service Award, World Trade Center Response Team, 2001
